《盈警響號》心通醫療(02160.HK)預計去年虧損擴至4.4-4.7億人民幣

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

《盈警響號》心通醫療(02160.HK)預計去年虧損擴至4.4-4.7億人民幣

阿思達克 03-01 01:48

心通醫療－Ｂ(02160.HK)發盈警，與上一年度淨虧損1.83億人民幣相比，預計2022年止年度錄得淨虧損介乎4.4--4.7億人民幣。預期增加主要因年內非現金及/或一次性虧損加；及對產品管線研發的持續投入和商業化的推進。全年收入預計不少於2.5億人民幣，增加25%。

心通醫療-B(02160.HK)

Relevant Stocks

心通醫療-B(02160.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

《盈警響號》心通醫療(02160.HK)預計去年虧損擴至4.4-4.7億人民幣

Services

About Us

Agreement Statement